Article metrics

Download PDFPDF

Original research
A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors

 

Online download statistics by month:

Online download statistics by month: March 2020 to July 2022

AbstractFullPdf
Mar 2020384384147
Apr 202020820875
May 2020949441
Jun 202011611649
Jul 2020707223
Aug 2020838347
Sep 202013613632
Oct 202011511537
Nov 2020858622
Dec 2020848437
Jan 202110910968
Feb 202111611630
Mar 202122522565
Apr 202118518567
May 202118818849
Jun 202116716739
Jul 202115815867
Aug 202112712728
Sep 202112812847
Oct 202114614762
Nov 202126526674
Dec 202113913832
Jan 202215716330
Feb 202213614232
Mar 202216416954
Apr 202220120843
May 202220220840
Jun 202218119138
Jul 202216517235
Total453445851410